Literature DB >> 167833

Characterization of human alpha-galactosidase A and B before and after neuraminidase treatment.

G Romeo, G Di Matteo, M D'urso, S C Li, Y T Li.   

Abstract

It has been previously reported that following neuraminidase treatment alpha-galactosidase A is converted into the B form, as revealed by electrophoresis. By a variety of techniques such as isoelectrofocusing, DEAE-chromatography and by enzyme kinetic parameters, no conversion of alpha-galactosidase A into B, or the reverse, could be detected after neuraminidase treatment. Only an apparent transformation of alpha-galactosidase A into B was revealed by Cellogel electrophoresis. In addition, a discrepancy was noticed between the pattern of electrophoretic migration on starch gel and Cellogel and the net electrical charges of the two alpha-galactosidases as deduced by isoelectrofocusing and DEAE-cellulose. Neuraminidase treatment did not affect the activity of alpha-galactosidase A towards the natural substrate, ceramidetrihexoside, but the activity of alpha-galactosidase B decreased by about 30% under the same conditions. The two forms of alpha-galactosidases A and B used in this study were extensively purified by classical procedures.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167833     DOI: 10.1016/0005-2744(75)90259-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity.

Authors:  J L Avila; J Convit
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

Review 2.  Glycosphingolipid hydrolases: properties and molecular genetics.

Authors:  M Wan Ho; A G Norden; J A Alhadeff; J S O'Brien
Journal:  Mol Cell Biochem       Date:  1977-10-07       Impact factor: 3.396

3.  Residual activity of alpha-galactosidase A in Fabry's disease.

Authors:  G Romeo; M D'Urso; A Pisacane; E Blum; A De Falco; A Ruffilli
Journal:  Biochem Genet       Date:  1975-10       Impact factor: 1.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.